

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.79301694 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.79301694 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.75285282 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.19406641 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.83867610 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60651037 |
| 7 | cellular extravasation (GO:0045123) | 4.59705731 |
| 8 | presynaptic membrane assembly (GO:0097105) | 4.41466451 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.36941251 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.32761802 |
| 11 | response to interleukin-15 (GO:0070672) | 4.29769524 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.29192687 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 4.19578314 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.18306233 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.17694679 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.15674647 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.12958162 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.12958162 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.12958162 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 4.12958162 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 4.12958162 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 4.12958162 |
| 23 | negative T cell selection (GO:0043383) | 4.00134796 |
| 24 | positive T cell selection (GO:0043368) | 3.99370584 |
| 25 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.98311037 |
| 26 | negative thymic T cell selection (GO:0045060) | 3.92597806 |
| 27 | postsynaptic membrane organization (GO:0001941) | 3.79750288 |
| 28 | presynaptic membrane organization (GO:0097090) | 3.79352404 |
| 29 | activated T cell proliferation (GO:0050798) | 3.75492005 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.74454485 |
| 31 | detection of other organism (GO:0098543) | 3.74222903 |
| 32 | neuron cell-cell adhesion (GO:0007158) | 3.73601823 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.71072391 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.62211907 |
| 35 | tolerance induction (GO:0002507) | 3.56425908 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.54606930 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.53436618 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51472277 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.46374564 |
| 40 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.42314944 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.42073296 |
| 42 | leukocyte aggregation (GO:0070486) | 3.39548212 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.38594901 |
| 44 | T cell selection (GO:0045058) | 3.35471626 |
| 45 | protein localization to synapse (GO:0035418) | 3.31949403 |
| 46 | detection of bacterium (GO:0016045) | 3.29252338 |
| 47 | microglial cell activation (GO:0001774) | 3.24963242 |
| 48 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.24804390 |
| 49 | macrophage activation (GO:0042116) | 3.18296661 |
| 50 | negative regulation of interleukin-12 production (GO:0032695) | 3.17911474 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16487618 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.15944374 |
| 53 | neuronal action potential propagation (GO:0019227) | 3.10944091 |
| 54 | Golgi to endosome transport (GO:0006895) | 3.10356144 |
| 55 | synaptic vesicle maturation (GO:0016188) | 3.10208719 |
| 56 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.08299163 |
| 57 | positive regulation of tolerance induction (GO:0002645) | 3.07041658 |
| 58 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.06373359 |
| 59 | positive regulation of dendritic spine development (GO:0060999) | 3.05782472 |
| 60 | vocalization behavior (GO:0071625) | 3.03286763 |
| 61 | membrane assembly (GO:0071709) | 3.01418313 |
| 62 | interferon-gamma production (GO:0032609) | 3.01010794 |
| 63 | T cell migration (GO:0072678) | 3.00665692 |
| 64 | thymic T cell selection (GO:0045061) | 3.00658745 |
| 65 | regulation of tolerance induction (GO:0002643) | 2.99646830 |
| 66 | positive regulation of granulocyte differentiation (GO:0030854) | 2.96641837 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 2.96199364 |
| 68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.95510526 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95122553 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94905677 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.94329075 |
| 72 | detection of biotic stimulus (GO:0009595) | 2.94132194 |
| 73 | histone H3-K36 demethylation (GO:0070544) | 2.93745395 |
| 74 | neutrophil mediated immunity (GO:0002446) | 2.93742938 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.93255727 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91811232 |
| 77 | response to host immune response (GO:0052572) | 2.91811232 |
| 78 | regulation of B cell differentiation (GO:0045577) | 2.88881940 |
| 79 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.88378999 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.84811147 |
| 81 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.84347528 |
| 82 | cellular potassium ion homeostasis (GO:0030007) | 2.84188174 |
| 83 | adult heart development (GO:0007512) | 2.82889561 |
| 84 | neutrophil activation involved in immune response (GO:0002283) | 2.82798913 |
| 85 | layer formation in cerebral cortex (GO:0021819) | 2.82635092 |
| 86 | myeloid leukocyte mediated immunity (GO:0002444) | 2.80782502 |
| 87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.80040463 |
| 88 | positive regulation of membrane potential (GO:0045838) | 2.79505176 |
| 89 | neutrophil activation (GO:0042119) | 2.78786653 |
| 90 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77901998 |
| 91 | gamma-aminobutyric acid transport (GO:0015812) | 2.77784389 |
| 92 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.77180752 |
| 93 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.75228289 |
| 94 | response to host (GO:0075136) | 2.75228289 |
| 95 | response to host defenses (GO:0052200) | 2.75228289 |
| 96 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.73409275 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.73005903 |
| 98 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.73005903 |
| 99 | response to peptidoglycan (GO:0032494) | 2.70595362 |
| 100 | cellular response to ethanol (GO:0071361) | 2.69276168 |
| 101 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.66850675 |
| 102 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66466851 |
| 103 | negative regulation of inclusion body assembly (GO:0090084) | 2.65992910 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.65079422 |
| 105 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.62310384 |
| 106 | negative regulation of adaptive immune response (GO:0002820) | 2.61471193 |
| 107 | germinal center formation (GO:0002467) | 2.61221889 |
| 108 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.60399226 |
| 109 | potassium ion import (GO:0010107) | 2.60252963 |
| 110 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.59910746 |
| 111 | regulation of histone H3-K27 methylation (GO:0061085) | 2.58375874 |
| 112 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.57434483 |
| 113 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.56751666 |
| 114 | mating behavior (GO:0007617) | 2.56544209 |
| 115 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.56344485 |
| 116 | regulation of synaptic vesicle transport (GO:1902803) | 2.55947426 |
| 117 | locomotory exploration behavior (GO:0035641) | 2.55074696 |
| 118 | positive regulation of mast cell activation (GO:0033005) | 2.55000997 |
| 119 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.54530673 |
| 120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54373241 |
| 121 | T cell receptor signaling pathway (GO:0050852) | 2.53227655 |
| 122 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.52855419 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 2.51473127 |
| 124 | regulation of mast cell activation (GO:0033003) | 2.50850660 |
| 125 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.50532047 |
| 126 | dendritic cell migration (GO:0036336) | 2.50165731 |
| 127 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.50134485 |
| 128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.50134485 |
| 129 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.49337342 |
| 130 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.48729143 |
| 131 | synaptic vesicle exocytosis (GO:0016079) | 2.48507085 |
| 132 | glutamate receptor signaling pathway (GO:0007215) | 2.48135348 |
| 133 | growth hormone receptor signaling pathway (GO:0060396) | 2.47945722 |
| 134 | regulation of dendritic spine development (GO:0060998) | 2.47921874 |
| 135 | activation of protein kinase A activity (GO:0034199) | 2.45944107 |
| 136 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.45557712 |
| 137 | negative regulation of B cell mediated immunity (GO:0002713) | 2.45380659 |
| 138 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.45380659 |
| 139 | mast cell activation (GO:0045576) | 2.44790950 |
| 140 | granulocyte activation (GO:0036230) | 2.43996496 |
| 141 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.43446843 |
| 142 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.42924362 |
| 143 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.42158228 |
| 144 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.41351529 |
| 145 | cerebellar granule cell differentiation (GO:0021707) | 2.39750436 |
| 146 | positive regulation of synapse assembly (GO:0051965) | 2.39515830 |
| 147 | membrane hyperpolarization (GO:0060081) | 2.39391741 |
| 148 | regulation of postsynaptic membrane potential (GO:0060078) | 2.38896800 |
| 149 | regulation of cell communication by electrical coupling (GO:0010649) | 2.38850042 |
| 150 | positive regulation of neurotransmitter transport (GO:0051590) | 2.37999791 |
| 151 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.37703435 |
| 152 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.37211875 |
| 153 | response to pheromone (GO:0019236) | 2.37200185 |
| 154 | regulation of respiratory system process (GO:0044065) | 2.37100045 |
| 155 | sodium ion export (GO:0071436) | 2.36954381 |
| 156 | neurotransmitter secretion (GO:0007269) | 2.34904716 |
| 157 | regulation of synapse structural plasticity (GO:0051823) | 2.34084013 |
| 158 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.33134306 |
| 159 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.32571135 |
| 160 | mechanosensory behavior (GO:0007638) | 2.31346512 |
| 161 | regulation of sequestering of triglyceride (GO:0010889) | 2.28097357 |
| 162 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.27374279 |
| 163 | synapse assembly (GO:0007416) | 2.26797304 |
| 164 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.26505001 |
| 165 | lymph vessel development (GO:0001945) | 2.24569902 |
| 166 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.24346655 |
| 167 | acylglycerol catabolic process (GO:0046464) | 2.24199123 |
| 168 | neutral lipid catabolic process (GO:0046461) | 2.24199123 |
| 169 | glutamate secretion (GO:0014047) | 2.22471205 |
| 170 | regulation of respiratory gaseous exchange (GO:0043576) | 2.21927407 |
| 171 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.21880162 |
| 172 | triglyceride catabolic process (GO:0019433) | 2.21867115 |
| 173 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.20529444 |
| 174 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.20152213 |
| 175 | endothelium development (GO:0003158) | 2.17626506 |
| 176 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.16458007 |
| 177 | cellular response to epinephrine stimulus (GO:0071872) | 2.15958782 |
| 178 | positive regulation of fatty acid oxidation (GO:0046321) | 2.15799702 |
| 179 | neuron recognition (GO:0008038) | 2.15470998 |
| 180 | membrane depolarization (GO:0051899) | 2.15064685 |
| 181 | transmission of nerve impulse (GO:0019226) | 2.14452428 |
| 182 | potassium ion homeostasis (GO:0055075) | 2.13180114 |
| 183 | long-term memory (GO:0007616) | 2.12334491 |
| 184 | neuron-neuron synaptic transmission (GO:0007270) | 2.11715887 |
| 185 | dendrite morphogenesis (GO:0048813) | 2.11490743 |
| 186 | cell differentiation in hindbrain (GO:0021533) | 2.10695406 |
| 187 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.10139009 |
| 188 | neurotransmitter transport (GO:0006836) | 2.09862709 |
| 189 | cell communication by electrical coupling (GO:0010644) | 2.09821215 |
| 190 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.09631355 |
| 191 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.09100251 |
| 192 | fatty acid transmembrane transport (GO:1902001) | 2.09029360 |
| 193 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.08907079 |
| 194 | regulation of actin filament-based movement (GO:1903115) | 2.07706577 |
| 195 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.07163507 |
| 196 | protein localization to endosome (GO:0036010) | 2.06966252 |
| 197 | dendritic spine morphogenesis (GO:0060997) | 2.06543956 |
| 198 | synaptic transmission, glutamatergic (GO:0035249) | 2.06086395 |
| 199 | neuromuscular process controlling posture (GO:0050884) | 2.05160250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.63553994 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.80988642 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.67464726 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94177195 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85585437 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65811183 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59182486 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.58087132 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52539983 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50872348 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.49054883 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.48218150 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.45534032 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42723194 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37622215 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.36909378 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.36909378 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29953594 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.27752511 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.27018318 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.24167750 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.22164259 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20793952 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19816855 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16761785 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16652956 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14222912 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08375106 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07855228 |
| 30 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06862080 |
| 31 | * MYB_26560356_Chip-Seq_TH2_Human | 2.05101881 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97920925 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96614285 |
| 34 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.96597490 |
| 35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95465003 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92825492 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87672250 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.86105359 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81077213 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77616798 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72636625 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.69587214 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69530589 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68824962 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66864846 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65267951 |
| 47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62910163 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59042764 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56143251 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53855544 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53155865 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50666065 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45272768 |
| 54 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45189101 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42088377 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38627034 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.37767590 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37032122 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.36558363 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36130723 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35942188 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34758495 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32207163 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31215451 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30324141 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30148870 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29773380 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29711813 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29701869 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28984461 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27959638 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27472249 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27391544 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27152916 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26349357 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26214151 |
| 77 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.24789646 |
| 78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.22911118 |
| 79 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22798276 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22519674 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22235304 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20826192 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20167829 |
| 84 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16952731 |
| 85 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16412682 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15180544 |
| 87 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14978067 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14646822 |
| 89 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14484135 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13322580 |
| 91 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13048839 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11170030 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10979482 |
| 94 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.10871159 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10456024 |
| 96 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.10152449 |
| 97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09072192 |
| 98 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08345553 |
| 99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07938816 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07889176 |
| 101 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07564314 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07438325 |
| 103 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07045726 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06542858 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05349986 |
| 106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05111738 |
| 107 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03152359 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03009356 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02579236 |
| 110 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02331952 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02095662 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02012503 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01065732 |
| 114 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01041385 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01030321 |
| 116 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00496884 |
| 117 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00407591 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00187380 |
| 119 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00012829 |
| 120 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99451169 |
| 121 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99193445 |
| 122 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98650406 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98593969 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96576635 |
| 125 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96128653 |
| 126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95899685 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95860251 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95847136 |
| 129 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95830687 |
| 130 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.95606804 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94864970 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94809100 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93250460 |
| 134 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92553678 |
| 135 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.92273726 |
| 136 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92148231 |
| 137 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91688606 |
| 138 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91486515 |
| 139 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89741414 |
| 140 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89242851 |
| 141 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89022006 |
| 142 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88730686 |
| 143 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88418694 |
| 144 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88191388 |
| 145 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88087088 |
| 146 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87733858 |
| 147 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87684525 |
| 148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87096559 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87096559 |
| 150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86840176 |
| 151 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86576623 |
| 152 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.86220112 |
| 153 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86011052 |
| 154 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85556635 |
| 155 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85332997 |
| 156 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84911454 |
| 157 | * AR_19668381_ChIP-Seq_PC3_Human | 0.84367736 |
| 158 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83084315 |
| 159 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83029087 |
| 160 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82910499 |
| 161 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82630240 |
| 162 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82388053 |
| 163 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82281193 |
| 164 | MAF_26560356_Chip-Seq_TH2_Human | 0.82052829 |
| 165 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.81258653 |
| 166 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80756640 |
| 167 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80626553 |
| 168 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79787751 |
| 169 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.75804931 |
| 170 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75497653 |
| 171 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74442333 |
| 172 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.74344910 |
| 173 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.72417521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.08046585 |
| 2 | MP0003303_peritoneal_inflammation | 3.53905900 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.32430946 |
| 4 | MP0003436_decreased_susceptibility_to | 3.16418281 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.92216776 |
| 6 | MP0000465_gastrointestinal_hemorrhage | 2.89448187 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.78741452 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.66296218 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.63407405 |
| 10 | MP0001800_abnormal_humoral_immune | 2.59511224 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.49685546 |
| 12 | MP0005671_abnormal_response_to | 2.43759078 |
| 13 | MP0009046_muscle_twitch | 2.36550690 |
| 14 | MP0002419_abnormal_innate_immunity | 2.33464251 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.31994269 |
| 16 | MP0006276_abnormal_autonomic_nervous | 2.26667260 |
| 17 | MP0002723_abnormal_immune_serum | 2.20508416 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.18575716 |
| 19 | MP0005025_abnormal_response_to | 2.18546364 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.17884223 |
| 21 | MP0001819_abnormal_immune_cell | 2.14870462 |
| 22 | MP0009745_abnormal_behavioral_response | 2.12994776 |
| 23 | MP0004130_abnormal_muscle_cell | 2.08444786 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.03291880 |
| 25 | MP0000685_abnormal_immune_system | 2.01117393 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.99503849 |
| 27 | MP0002064_seizures | 1.99489350 |
| 28 | MP0009379_abnormal_foot_pigmentation | 1.98170532 |
| 29 | MP0001790_abnormal_immune_system | 1.96518090 |
| 30 | MP0005387_immune_system_phenotype | 1.96518090 |
| 31 | MP0009785_altered_susceptibility_to | 1.95301548 |
| 32 | MP0004215_abnormal_myocardial_fiber | 1.92972018 |
| 33 | MP0008260_abnormal_autophagy | 1.89470843 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.88440152 |
| 35 | MP0005670_abnormal_white_adipose | 1.86867879 |
| 36 | MP0002822_catalepsy | 1.85492209 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.85096998 |
| 38 | MP0001968_abnormal_touch/_nociception | 1.84387726 |
| 39 | MP0002272_abnormal_nervous_system | 1.84277420 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.83362282 |
| 41 | MP0008569_lethality_at_weaning | 1.83352609 |
| 42 | MP0000751_myopathy | 1.82552278 |
| 43 | MP0004272_abnormal_basement_membrane | 1.78803540 |
| 44 | MP0002398_abnormal_bone_marrow | 1.76869533 |
| 45 | MP0002405_respiratory_system_inflammati | 1.76610041 |
| 46 | MP0004270_analgesia | 1.72317970 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.71211147 |
| 48 | MP0006082_CNS_inflammation | 1.70323141 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.68843112 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.68590021 |
| 51 | MP0000716_abnormal_immune_system | 1.67802710 |
| 52 | MP0001851_eye_inflammation | 1.67315146 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.67077601 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.66878585 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.64112322 |
| 56 | MP0002063_abnormal_learning/memory/cond | 1.61467171 |
| 57 | MP0001879_abnormal_lymphatic_vessel | 1.60789977 |
| 58 | MP0001486_abnormal_startle_reflex | 1.59433766 |
| 59 | MP0004947_skin_inflammation | 1.59227638 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.59209413 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.56306820 |
| 62 | MP0005423_abnormal_somatic_nervous | 1.55208184 |
| 63 | MP0004883_abnormal_blood_vessel | 1.54762428 |
| 64 | MP0005360_urolithiasis | 1.53612128 |
| 65 | MP0001440_abnormal_grooming_behavior | 1.52707399 |
| 66 | MP0002572_abnormal_emotion/affect_behav | 1.50313781 |
| 67 | MP0003866_abnormal_defecation | 1.48089201 |
| 68 | MP0005535_abnormal_body_temperature | 1.47836355 |
| 69 | MP0002722_abnormal_immune_system | 1.46180341 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.45238085 |
| 71 | MP0002933_joint_inflammation | 1.45191989 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.44346783 |
| 73 | MP0002009_preneoplasia | 1.42583441 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.42126856 |
| 75 | MP0003868_abnormal_feces_composition | 1.41812410 |
| 76 | MP0006054_spinal_hemorrhage | 1.41472857 |
| 77 | MP0005409_darkened_coat_color | 1.40764219 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.40482935 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 1.40468298 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 1.40361719 |
| 81 | MP0004484_altered_response_of | 1.39386286 |
| 82 | MP0002734_abnormal_mechanical_nocicepti | 1.37980499 |
| 83 | MP0003172_abnormal_lysosome_physiology | 1.35640218 |
| 84 | MP0002638_abnormal_pupillary_reflex | 1.35526092 |
| 85 | MP0005666_abnormal_adipose_tissue | 1.35171613 |
| 86 | MP0002971_abnormal_brown_adipose | 1.34360274 |
| 87 | MP0010329_abnormal_lipoprotein_level | 1.33732633 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.32914265 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 1.31987595 |
| 90 | MP0005310_abnormal_salivary_gland | 1.31325871 |
| 91 | MP0003183_abnormal_peptide_metabolism | 1.29643598 |
| 92 | MP0009764_decreased_sensitivity_to | 1.27326559 |
| 93 | MP0005451_abnormal_body_composition | 1.26473304 |
| 94 | MP0002429_abnormal_blood_cell | 1.24646745 |
| 95 | MP0003646_muscle_fatigue | 1.24549407 |
| 96 | MP0004085_abnormal_heartbeat | 1.24535524 |
| 97 | MP0002184_abnormal_innervation | 1.23829992 |
| 98 | MP0001984_abnormal_olfaction | 1.22441134 |
| 99 | MP0002006_tumorigenesis | 1.21545073 |
| 100 | MP0002998_abnormal_bone_remodeling | 1.20191223 |
| 101 | MP0005386_behavior/neurological_phenoty | 1.19188844 |
| 102 | MP0004924_abnormal_behavior | 1.19188844 |
| 103 | MP0003633_abnormal_nervous_system | 1.18339855 |
| 104 | MP0002557_abnormal_social/conspecific_i | 1.17715177 |
| 105 | MP0005375_adipose_tissue_phenotype | 1.17632794 |
| 106 | MP0004036_abnormal_muscle_relaxation | 1.17389220 |
| 107 | MP0001970_abnormal_pain_threshold | 1.16733353 |
| 108 | MP0002909_abnormal_adrenal_gland | 1.15681787 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14503132 |
| 110 | MP0002733_abnormal_thermal_nociception | 1.14357400 |
| 111 | MP0001661_extended_life_span | 1.14046660 |
| 112 | MP0009333_abnormal_splenocyte_physiolog | 1.12009534 |
| 113 | MP0002736_abnormal_nociception_after | 1.11553249 |
| 114 | MP0003724_increased_susceptibility_to | 1.11327671 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 1.10284938 |
| 116 | MP0005164_abnormal_response_to | 1.09977785 |
| 117 | MP0003011_delayed_dark_adaptation | 1.09422835 |
| 118 | MP0002332_abnormal_exercise_endurance | 1.08400304 |
| 119 | MP0002132_abnormal_respiratory_system | 1.08271532 |
| 120 | MP0005085_abnormal_gallbladder_physiolo | 1.08135546 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 1.07937977 |
| 122 | MP0000015_abnormal_ear_pigmentation | 1.07916596 |
| 123 | MP0001502_abnormal_circadian_rhythm | 1.07375432 |
| 124 | MP0002396_abnormal_hematopoietic_system | 1.06183652 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 1.06029857 |
| 126 | MP0003787_abnormal_imprinting | 1.04093790 |
| 127 | MP0006138_congestive_heart_failure | 1.02627549 |
| 128 | MP0001188_hyperpigmentation | 1.01904920 |
| 129 | MP0000249_abnormal_blood_vessel | 1.01237035 |
| 130 | MP0004381_abnormal_hair_follicle | 1.01114231 |
| 131 | MP0003329_amyloid_beta_deposits | 1.00689711 |
| 132 | MP0005595_abnormal_vascular_smooth | 1.00266752 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.99571870 |
| 134 | MP0005330_cardiomyopathy | 0.98734649 |
| 135 | MP0004084_abnormal_cardiac_muscle | 0.98675959 |
| 136 | MP0005620_abnormal_muscle_contractility | 0.97728066 |
| 137 | MP0000778_abnormal_nervous_system | 0.97405652 |
| 138 | MP0009278_abnormal_bone_marrow | 0.96517709 |
| 139 | MP0008874_decreased_physiological_sensi | 0.94683328 |
| 140 | MP0005365_abnormal_bile_salt | 0.94260046 |
| 141 | MP0003091_abnormal_cell_migration | 0.93319107 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.92017944 |
| 143 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91639383 |
| 144 | MP0002735_abnormal_chemical_nociception | 0.90187032 |
| 145 | MP0008469_abnormal_protein_level | 0.89883709 |
| 146 | MP0005253_abnormal_eye_physiology | 0.89880402 |
| 147 | MP0005166_decreased_susceptibility_to | 0.89604105 |
| 148 | MP0004142_abnormal_muscle_tone | 0.89034711 |
| 149 | MP0005165_increased_susceptibility_to | 0.88522638 |
| 150 | MP0005397_hematopoietic_system_phenotyp | 0.88319555 |
| 151 | MP0001545_abnormal_hematopoietic_system | 0.88319555 |
| 152 | MP0002066_abnormal_motor_capabilities/c | 0.88305226 |
| 153 | MP0000767_abnormal_smooth_muscle | 0.88205483 |
| 154 | MP0008004_abnormal_stomach_pH | 0.87742256 |
| 155 | MP0004808_abnormal_hematopoietic_stem | 0.87528776 |
| 156 | MP0005388_respiratory_system_phenotype | 0.87262325 |
| 157 | MP0002133_abnormal_respiratory_system | 0.87262325 |
| 158 | MP0002118_abnormal_lipid_homeostasis | 0.87060413 |
| 159 | MP0003690_abnormal_glial_cell | 0.86691788 |
| 160 | MP0002972_abnormal_cardiac_muscle | 0.86019817 |
| 161 | MP0002229_neurodegeneration | 0.84693417 |
| 162 | MP0004510_myositis | 0.83497805 |
| 163 | MP0000003_abnormal_adipose_tissue | 0.82765053 |
| 164 | MP0000920_abnormal_myelination | 0.82499518 |
| 165 | MP0003137_abnormal_impulse_conducting | 0.82344199 |
| 166 | MP0003828_pulmonary_edema | 0.81599883 |
| 167 | MP0008775_abnormal_heart_ventricle | 0.81494250 |
| 168 | MP0000858_altered_metastatic_potential | 0.81482789 |
| 169 | MP0005084_abnormal_gallbladder_morpholo | 0.80249726 |
| 170 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79769175 |
| 171 | MP0002090_abnormal_vision | 0.79713467 |
| 172 | MP0003045_fibrosis | 0.78369481 |
| 173 | MP0001873_stomach_inflammation | 0.78320154 |
| 174 | MP0001915_intracranial_hemorrhage | 0.78157487 |
| 175 | MP0003631_nervous_system_phenotype | 0.78013435 |
| 176 | MP0000604_amyloidosis | 0.75581132 |
| 177 | MP0009115_abnormal_fat_cell | 0.74161722 |
| 178 | MP0003448_altered_tumor_morphology | 0.73967682 |
| 179 | MP0003075_altered_response_to | 0.72439792 |
| 180 | MP0001986_abnormal_taste_sensitivity | 0.69429105 |
| 181 | MP0003279_aneurysm | 0.67668912 |
| 182 | MP0009765_abnormal_xenobiotic_induced | 0.61960482 |
| 183 | MP0009763_increased_sensitivity_to | 0.57392370 |
| 184 | MP0008961_abnormal_basal_metabolism | 0.56523141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.25402533 |
| 2 | T lymphocytopenia (HP:0005403) | 4.44270332 |
| 3 | Myositis (HP:0100614) | 4.43688132 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.34868824 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.31494247 |
| 6 | Optic neuritis (HP:0100653) | 4.31494247 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.28750776 |
| 8 | Focal motor seizures (HP:0011153) | 4.23372738 |
| 9 | Orchitis (HP:0100796) | 4.16563207 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.06707672 |
| 11 | Stomatitis (HP:0010280) | 4.05212984 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.05085190 |
| 13 | Pseudobulbar signs (HP:0002200) | 3.86453595 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.45298426 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.43865513 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.38168047 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.30317623 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.27921319 |
| 19 | Action tremor (HP:0002345) | 3.25869739 |
| 20 | Drooling (HP:0002307) | 3.24492304 |
| 21 | Excessive salivation (HP:0003781) | 3.24492304 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23556824 |
| 23 | Atonic seizures (HP:0010819) | 3.17014134 |
| 24 | Keratoconjunctivitis (HP:0001096) | 3.13892749 |
| 25 | Visual hallucinations (HP:0002367) | 3.12993460 |
| 26 | Focal seizures (HP:0007359) | 3.12694336 |
| 27 | Cone-rod dystrophy (HP:0000548) | 3.12604452 |
| 28 | Progressive inability to walk (HP:0002505) | 3.02121175 |
| 29 | Abnormality of macrophages (HP:0004311) | 2.96390833 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.95287002 |
| 31 | Vasculitis (HP:0002633) | 2.88801129 |
| 32 | Abnormality of T cells (HP:0002843) | 2.87029991 |
| 33 | Recurrent skin infections (HP:0001581) | 2.86976779 |
| 34 | Sudden death (HP:0001699) | 2.86764872 |
| 35 | Decreased circulating renin level (HP:0003351) | 2.85915947 |
| 36 | Leukocytosis (HP:0001974) | 2.84091351 |
| 37 | Dysmetric saccades (HP:0000641) | 2.82670308 |
| 38 | Hematochezia (HP:0002573) | 2.82300004 |
| 39 | Hemiplegia (HP:0002301) | 2.81754062 |
| 40 | Meningitis (HP:0001287) | 2.81071951 |
| 41 | Prolonged bleeding time (HP:0003010) | 2.79795868 |
| 42 | Metabolic alkalosis (HP:0200114) | 2.79073841 |
| 43 | Gingivitis (HP:0000230) | 2.79018780 |
| 44 | Encephalitis (HP:0002383) | 2.78500376 |
| 45 | Hemoptysis (HP:0002105) | 2.76396383 |
| 46 | Scanning speech (HP:0002168) | 2.74592307 |
| 47 | Abnormality of renin-angiotensin system (HP:0000847) | 2.74031686 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71446809 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71446809 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.71310476 |
| 51 | Cerebral hemorrhage (HP:0001342) | 2.69950051 |
| 52 | Chest pain (HP:0100749) | 2.69365726 |
| 53 | Myokymia (HP:0002411) | 2.68835281 |
| 54 | Febrile seizures (HP:0002373) | 2.67668538 |
| 55 | Pustule (HP:0200039) | 2.66927366 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.66680058 |
| 57 | Subacute progressive viral hepatitis (HP:0006572) | 2.65451735 |
| 58 | Gaze-evoked nystagmus (HP:0000640) | 2.64826056 |
| 59 | Dysmetria (HP:0001310) | 2.63074676 |
| 60 | Hyperactive renin-angiotensin system (HP:0000841) | 2.60147680 |
| 61 | Eosinophilia (HP:0001880) | 2.57510017 |
| 62 | Pigmentary retinal degeneration (HP:0001146) | 2.57449617 |
| 63 | Pulmonary embolism (HP:0002204) | 2.53389242 |
| 64 | Stomach cancer (HP:0012126) | 2.50721132 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.49838128 |
| 66 | Granulocytopenia (HP:0001913) | 2.49503789 |
| 67 | Absence seizures (HP:0002121) | 2.48454100 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.47056814 |
| 69 | Gingival bleeding (HP:0000225) | 2.46756193 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.46142423 |
| 71 | Neonatal onset (HP:0003623) | 2.46101395 |
| 72 | Exercise-induced myalgia (HP:0003738) | 2.45200849 |
| 73 | Arterial thrombosis (HP:0004420) | 2.44962448 |
| 74 | Optic disc pallor (HP:0000543) | 2.44877557 |
| 75 | Recurrent viral infections (HP:0004429) | 2.44202588 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.43708291 |
| 77 | Agitation (HP:0000713) | 2.43587982 |
| 78 | Anxiety (HP:0000739) | 2.41871406 |
| 79 | Epistaxis (HP:0000421) | 2.41524402 |
| 80 | Hyperglycinuria (HP:0003108) | 2.39390180 |
| 81 | Intellectual disability, progressive (HP:0006887) | 2.39172204 |
| 82 | Deep venous thrombosis (HP:0002625) | 2.39058497 |
| 83 | Hyperlipoproteinemia (HP:0010980) | 2.38487634 |
| 84 | Amyotrophic lateral sclerosis (HP:0007354) | 2.37004831 |
| 85 | Increased IgE level (HP:0003212) | 2.36169574 |
| 86 | Urticaria (HP:0001025) | 2.35092082 |
| 87 | Abnormality of macular pigmentation (HP:0008002) | 2.33190155 |
| 88 | Slow saccadic eye movements (HP:0000514) | 2.31053937 |
| 89 | Central scotoma (HP:0000603) | 2.30471597 |
| 90 | Broad-based gait (HP:0002136) | 2.29147540 |
| 91 | Inflammation of the large intestine (HP:0002037) | 2.28925042 |
| 92 | Hyperventilation (HP:0002883) | 2.28671893 |
| 93 | Abnormal hemoglobin (HP:0011902) | 2.27521042 |
| 94 | Generalized tonic-clonic seizures (HP:0002069) | 2.27458302 |
| 95 | Syncope (HP:0001279) | 2.27281161 |
| 96 | Hyperglycinemia (HP:0002154) | 2.26737282 |
| 97 | Prolonged QT interval (HP:0001657) | 2.26469896 |
| 98 | Intention tremor (HP:0002080) | 2.26329621 |
| 99 | Neurofibrillary tangles (HP:0002185) | 2.26178494 |
| 100 | Papilledema (HP:0001085) | 2.24968475 |
| 101 | Cellulitis (HP:0100658) | 2.24668768 |
| 102 | Ketoacidosis (HP:0001993) | 2.22919411 |
| 103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22366187 |
| 104 | Obstructive lung disease (HP:0006536) | 2.22366187 |
| 105 | Papillary thyroid carcinoma (HP:0002895) | 2.21970708 |
| 106 | Recurrent bronchitis (HP:0002837) | 2.21688104 |
| 107 | Depression (HP:0000716) | 2.21439306 |
| 108 | Autoimmune thrombocytopenia (HP:0001973) | 2.19747340 |
| 109 | Genetic anticipation (HP:0003743) | 2.19241925 |
| 110 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.18646409 |
| 111 | Peritonitis (HP:0002586) | 2.17949329 |
| 112 | Abnormality of salivation (HP:0100755) | 2.17786461 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 2.17355424 |
| 114 | Congenital stationary night blindness (HP:0007642) | 2.17168556 |
| 115 | Hypochromic anemia (HP:0001931) | 2.16768914 |
| 116 | Increased variability in muscle fiber diameter (HP:0003557) | 2.16049950 |
| 117 | Dialeptic seizures (HP:0011146) | 2.15874535 |
| 118 | Panhypogammaglobulinemia (HP:0003139) | 2.15863556 |
| 119 | Supranuclear gaze palsy (HP:0000605) | 2.15671014 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 2.14416700 |
| 121 | Hemiparesis (HP:0001269) | 2.14178297 |
| 122 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.13007213 |
| 123 | Calf muscle hypertrophy (HP:0008981) | 2.10478570 |
| 124 | Hypothermia (HP:0002045) | 2.09320061 |
| 125 | Truncal ataxia (HP:0002078) | 2.08469837 |
| 126 | Limb dystonia (HP:0002451) | 2.07461486 |
| 127 | Abnormality of binocular vision (HP:0011514) | 2.06482771 |
| 128 | Diplopia (HP:0000651) | 2.06482771 |
| 129 | Hypercortisolism (HP:0001578) | 2.05610696 |
| 130 | Ketosis (HP:0001946) | 2.03919995 |
| 131 | Abnormal eating behavior (HP:0100738) | 2.03606179 |
| 132 | Papilloma (HP:0012740) | 2.03335712 |
| 133 | Verrucae (HP:0200043) | 2.03335712 |
| 134 | Viral hepatitis (HP:0006562) | 2.03103697 |
| 135 | Ulnar claw (HP:0001178) | 2.01538367 |
| 136 | Status epilepticus (HP:0002133) | 2.01322335 |
| 137 | Osteomyelitis (HP:0002754) | 2.00759254 |
| 138 | Epileptic encephalopathy (HP:0200134) | 2.00126691 |
| 139 | Cerebral inclusion bodies (HP:0100314) | 1.97969051 |
| 140 | Atrial fibrillation (HP:0005110) | 1.97872987 |
| 141 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.97743544 |
| 142 | Abnormality of glycine metabolism (HP:0010895) | 1.97743544 |
| 143 | Rapidly progressive (HP:0003678) | 1.97467938 |
| 144 | Colitis (HP:0002583) | 1.97403443 |
| 145 | Gangrene (HP:0100758) | 1.96538705 |
| 146 | Microcytic anemia (HP:0001935) | 1.96198244 |
| 147 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95992503 |
| 148 | Abnormality of T cell physiology (HP:0011840) | 1.95547405 |
| 149 | Hyporeflexia of lower limbs (HP:0002600) | 1.95458323 |
| 150 | Myotonia (HP:0002486) | 1.95209164 |
| 151 | Abnormal social behavior (HP:0012433) | 1.94657868 |
| 152 | Impaired social interactions (HP:0000735) | 1.94657868 |
| 153 | Primary atrial arrhythmia (HP:0001692) | 1.94221301 |
| 154 | Difficulty running (HP:0009046) | 1.94194972 |
| 155 | Pheochromocytoma (HP:0002666) | 1.93489170 |
| 156 | Alveolar cell carcinoma (HP:0006519) | 1.93074577 |
| 157 | Abnormality of chloride homeostasis (HP:0011422) | 1.92828186 |
| 158 | Conjunctival telangiectasia (HP:0000524) | 1.92811158 |
| 159 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.91206078 |
| 160 | Episodic fever (HP:0001954) | 1.90974355 |
| 161 | Anorexia (HP:0002039) | 1.90735568 |
| 162 | Spontaneous hematomas (HP:0007420) | 1.89098371 |
| 163 | Sepsis (HP:0100806) | 1.89027633 |
| 164 | Growth hormone excess (HP:0000845) | 1.87393278 |
| 165 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86344871 |
| 166 | Broad metatarsal (HP:0001783) | 1.86172317 |
| 167 | Nonprogressive disorder (HP:0003680) | 1.84824086 |
| 168 | Peripheral hypomyelination (HP:0007182) | 1.84712035 |
| 169 | Abnormality of the columella (HP:0009929) | 1.84707895 |
| 170 | Postural instability (HP:0002172) | 1.84243940 |
| 171 | Hypoglycemic coma (HP:0001325) | 1.83752906 |
| 172 | Amblyopia (HP:0000646) | 1.83670783 |
| 173 | Thyroiditis (HP:0100646) | 1.83348017 |
| 174 | Severe combined immunodeficiency (HP:0004430) | 1.83277010 |
| 175 | Increased IgM level (HP:0003496) | 1.83082043 |
| 176 | Poor eye contact (HP:0000817) | 1.82810800 |
| 177 | Adrenal overactivity (HP:0002717) | 1.82447817 |
| 178 | Vertigo (HP:0002321) | 1.81549104 |
| 179 | Xanthomatosis (HP:0000991) | 1.81396187 |
| 180 | Prolonged partial thromboplastin time (HP:0003645) | 1.80305750 |
| 181 | Abnormality of the endocardium (HP:0004306) | 1.80266489 |
| 182 | Amelogenesis imperfecta (HP:0000705) | 1.80104711 |
| 183 | Supraventricular arrhythmia (HP:0005115) | 1.78421906 |
| 184 | Lymphopenia (HP:0001888) | 1.77945407 |
| 185 | Amyloidosis (HP:0011034) | 1.75867423 |
| 186 | Glomerulonephritis (HP:0000099) | 1.75789109 |
| 187 | Hypergammaglobulinemia (HP:0010702) | 1.74852028 |
| 188 | Supraventricular tachycardia (HP:0004755) | 1.74484524 |
| 189 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73946029 |
| 190 | Polycythemia (HP:0001901) | 1.73277184 |
| 191 | Abnormality of the peritoneum (HP:0002585) | 1.73226753 |
| 192 | Abnormality of the pleura (HP:0002103) | 1.68284283 |
| 193 | Keratitis (HP:0000491) | 1.67469890 |
| 194 | Increased CSF protein (HP:0002922) | 1.67139003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK38 | 4.49018798 |
| 2 | PRKD2 | 3.83654449 |
| 3 | TIE1 | 3.15983844 |
| 4 | MAP4K1 | 2.78436477 |
| 5 | CASK | 2.70656624 |
| 6 | TXK | 2.67609267 |
| 7 | KDR | 2.41845569 |
| 8 | ZAP70 | 2.17642175 |
| 9 | MAPK15 | 2.07800066 |
| 10 | BLK | 2.02680226 |
| 11 | PRPF4B | 2.00673152 |
| 12 | MAP2K3 | 1.94906395 |
| 13 | TYK2 | 1.94686609 |
| 14 | IKBKE | 1.84254079 |
| 15 | TAOK3 | 1.72921213 |
| 16 | MAP3K14 | 1.70952260 |
| 17 | IRAK4 | 1.70498885 |
| 18 | NTRK3 | 1.69501068 |
| 19 | BTK | 1.69331251 |
| 20 | JAK3 | 1.60872269 |
| 21 | FGR | 1.57830615 |
| 22 | ITK | 1.56771869 |
| 23 | JAK1 | 1.56569293 |
| 24 | GRK7 | 1.55688706 |
| 25 | SYK | 1.55083337 |
| 26 | RIPK1 | 1.53820165 |
| 27 | TSSK6 | 1.53571164 |
| 28 | MAP2K4 | 1.53034317 |
| 29 | HCK | 1.51669982 |
| 30 | PHKG2 | 1.49753978 |
| 31 | PHKG1 | 1.49753978 |
| 32 | MAP3K13 | 1.47007882 |
| 33 | TNIK | 1.45845654 |
| 34 | TEC | 1.45690218 |
| 35 | CAMK1G | 1.45027678 |
| 36 | TGFBR2 | 1.42013552 |
| 37 | IRAK2 | 1.40383100 |
| 38 | YES1 | 1.39170251 |
| 39 | UHMK1 | 1.37921563 |
| 40 | MAP3K4 | 1.34157252 |
| 41 | GRK5 | 1.32821068 |
| 42 | PRKD1 | 1.32657338 |
| 43 | STK39 | 1.31450027 |
| 44 | MAP3K2 | 1.30211720 |
| 45 | SIK2 | 1.28830359 |
| 46 | LCK | 1.26707224 |
| 47 | HIPK2 | 1.25557786 |
| 48 | INSRR | 1.23377952 |
| 49 | NTRK2 | 1.20102027 |
| 50 | NLK | 1.19307689 |
| 51 | JAK2 | 1.18832065 |
| 52 | FGFR2 | 1.17095971 |
| 53 | DAPK2 | 1.16505904 |
| 54 | MAP2K7 | 1.15628017 |
| 55 | FES | 1.15317363 |
| 56 | WNK1 | 1.13329860 |
| 57 | PIK3CG | 1.09024034 |
| 58 | MINK1 | 1.08435719 |
| 59 | GRK6 | 1.07841555 |
| 60 | EPHA4 | 1.07430622 |
| 61 | FRK | 1.06712178 |
| 62 | LYN | 1.06199303 |
| 63 | PNCK | 1.05949444 |
| 64 | MAP3K6 | 1.04592495 |
| 65 | FER | 1.03578985 |
| 66 | CAMK2A | 1.03189988 |
| 67 | KIT | 1.02778488 |
| 68 | MARK1 | 1.02725175 |
| 69 | CAMK2B | 1.02387570 |
| 70 | SIK3 | 1.01033346 |
| 71 | MAPKAPK5 | 0.99672035 |
| 72 | MAP3K9 | 0.99647074 |
| 73 | MAP3K12 | 0.99003211 |
| 74 | MARK3 | 0.98685350 |
| 75 | EPHA3 | 0.98602718 |
| 76 | EPHB1 | 0.96656020 |
| 77 | MAP3K3 | 0.95591684 |
| 78 | GRK1 | 0.95183077 |
| 79 | MAPK12 | 0.95139052 |
| 80 | TBK1 | 0.95032239 |
| 81 | WNK4 | 0.95012705 |
| 82 | PAK6 | 0.93980762 |
| 83 | MAPK7 | 0.92507031 |
| 84 | NTRK1 | 0.90302668 |
| 85 | CAMKK2 | 0.89787704 |
| 86 | SGK223 | 0.89017445 |
| 87 | SGK494 | 0.89017445 |
| 88 | BMPR2 | 0.88684911 |
| 89 | PRKCH | 0.86115788 |
| 90 | IRAK1 | 0.85675912 |
| 91 | * STK11 | 0.85438203 |
| 92 | SIK1 | 0.84359610 |
| 93 | CDK5 | 0.84143750 |
| 94 | CAMK2D | 0.83057083 |
| 95 | PTK2B | 0.82287056 |
| 96 | MYLK | 0.81955533 |
| 97 | LMTK2 | 0.81147714 |
| 98 | PDK1 | 0.80273545 |
| 99 | CAMK1 | 0.78106157 |
| 100 | CAMK4 | 0.77528228 |
| 101 | CAMK1D | 0.75567702 |
| 102 | RET | 0.75133427 |
| 103 | SGK2 | 0.73734581 |
| 104 | PINK1 | 0.73243284 |
| 105 | DMPK | 0.73050616 |
| 106 | PRKAA2 | 0.72524192 |
| 107 | IKBKB | 0.72353452 |
| 108 | PDGFRB | 0.72238168 |
| 109 | MARK2 | 0.70648584 |
| 110 | FGFR4 | 0.69553517 |
| 111 | TRIB3 | 0.69151138 |
| 112 | RAF1 | 0.67965503 |
| 113 | TYRO3 | 0.67227380 |
| 114 | AKT3 | 0.66177110 |
| 115 | TAOK1 | 0.64960579 |
| 116 | OXSR1 | 0.64147447 |
| 117 | BRD4 | 0.63641081 |
| 118 | PRKCQ | 0.63207659 |
| 119 | PAK3 | 0.62702228 |
| 120 | MAP3K7 | 0.62553148 |
| 121 | ACVR1B | 0.61698009 |
| 122 | EPHB2 | 0.61334495 |
| 123 | CAMK2G | 0.61291828 |
| 124 | BCKDK | 0.58674736 |
| 125 | TRPM7 | 0.57463467 |
| 126 | PIM1 | 0.55644897 |
| 127 | DYRK1B | 0.55404847 |
| 128 | CSK | 0.55155973 |
| 129 | CAMKK1 | 0.55152160 |
| 130 | PKN1 | 0.53065742 |
| 131 | KSR2 | 0.53047653 |
| 132 | KSR1 | 0.52649413 |
| 133 | PIK3CA | 0.52583180 |
| 134 | CSNK1G1 | 0.50730425 |
| 135 | PRKCE | 0.50329198 |
| 136 | SGK3 | 0.50273683 |
| 137 | FGFR3 | 0.49994735 |
| 138 | DYRK1A | 0.49237848 |
| 139 | MUSK | 0.48343783 |
| 140 | TNK2 | 0.48133336 |
| 141 | CSF1R | 0.48086305 |
| 142 | CDK6 | 0.47775636 |
| 143 | STK10 | 0.47158730 |
| 144 | CSNK1G2 | 0.46691761 |
| 145 | CDK12 | 0.45839869 |
| 146 | EGFR | 0.45535524 |
| 147 | RIPK4 | 0.45418885 |
| 148 | FYN | 0.45390010 |
| 149 | PDPK1 | 0.45233020 |
| 150 | MAP3K1 | 0.45095644 |
| 151 | SGK1 | 0.44069981 |
| 152 | ADRBK1 | 0.43246732 |
| 153 | CLK1 | 0.41762010 |
| 154 | PRKAA1 | 0.40703287 |
| 155 | MAPK13 | 0.40341339 |
| 156 | NEK6 | 0.38886765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.45388758 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17710355 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.98205088 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.97476416 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.96890759 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96741690 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 1.89976520 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88910769 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.88052356 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 1.76945456 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 1.74950328 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74775459 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.73680694 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66578746 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.66121779 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.64385416 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.62338270 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62191821 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.60267140 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55903251 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.54963596 |
| 22 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.53316761 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.51177232 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49403777 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.48219647 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45039362 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.42893914 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42691956 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42670948 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.41695051 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.39950194 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.38375467 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37416636 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36955063 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36660116 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35391306 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35107214 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34219001 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34170586 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 1.33075609 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32957356 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.29005099 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.28155225 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.26190878 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25721275 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25099392 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.25062578 |
| 48 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.24485767 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24318526 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.23539165 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22527804 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21908623 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21743200 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21583185 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21454353 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19433507 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19307862 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19240123 |
| 59 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18846698 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 1.18663392 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18631586 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17054930 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16183345 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15919620 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.15560036 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 1.15387790 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 1.13371041 |
| 68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11733276 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.11712628 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10836113 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10437211 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09701882 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08504319 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.08327085 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08241135 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07678887 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.07121661 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 1.06424403 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 1.05624786 |
| 80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04317705 |
| 81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03430361 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00722209 |
| 83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.99274766 |
| 84 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99077496 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99003343 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.98292855 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96422112 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94333314 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93902416 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92725794 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92043902 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91607651 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91559104 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.91071148 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90449557 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89564193 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.89306431 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88557539 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88320234 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86194992 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85990385 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.85894052 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85762829 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83795215 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83174512 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82923595 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82133832 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80215294 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78699549 |
| 110 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78642503 |
| 111 | Melanogenesis_Homo sapiens_hsa04916 | 0.78237557 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76063611 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76029285 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75910991 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75627553 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75092841 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.75079106 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.74759290 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74755273 |
| 120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74659242 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73819202 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73751025 |
| 123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72806222 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.72685237 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.72158851 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72059552 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71821082 |
| 128 | Shigellosis_Homo sapiens_hsa05131 | 0.70696513 |
| 129 | Gap junction_Homo sapiens_hsa04540 | 0.70304109 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70229759 |
| 131 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69434591 |
| 132 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68179866 |
| 133 | Phagosome_Homo sapiens_hsa04145 | 0.67832083 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67666825 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65972341 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65569935 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.65374442 |
| 138 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63943831 |
| 139 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62920713 |
| 140 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62382781 |
| 141 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62225477 |
| 142 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61729243 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61597766 |
| 144 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61313360 |
| 145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60946683 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.60522870 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60116014 |
| 148 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57953038 |
| 149 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57573773 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56971032 |
| 151 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56832828 |
| 152 | ABC transporters_Homo sapiens_hsa02010 | 0.55814866 |
| 153 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54352281 |
| 154 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53678238 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53217553 |
| 156 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53137992 |
| 157 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52873594 |
| 158 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52592502 |
| 159 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52357028 |
| 160 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52155646 |
| 161 | Salmonella infection_Homo sapiens_hsa05132 | 0.51852808 |
| 162 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51436072 |
| 163 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50559300 |
| 164 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49736141 |
| 165 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48277372 |
| 166 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45454058 |
| 167 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43010069 |
| 168 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42981627 |
| 169 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41019117 |
| 170 | Insulin resistance_Homo sapiens_hsa04931 | 0.40227283 |
| 171 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39591071 |
| 172 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38978642 |

